U.S. pharma big copyright scrapped two experimental weight loss products last 12 months—a at the time-daily capsule, lotiglipron, due to elevated liver enzymes as well as a two times-every day pill, danuglipron, on account of solid Unwanted side effects—but CEO Albert Bourla has ment